Legg Mason Asset Management’s Teva Pharmaceuticals TEVA Stock Holding History

Legg Mason Asset Management’s Portfolio TEVA Stock Details TEVA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q3	–	Sell	-11,500	Closed	-$578K	–	116
2016 Q2	$578K	Sell	11,500 -300	-3%	-$16K	0.62%	87
2016 Q1	$632K	Hold	11,800	–	–	0.65%	83
2015 Q4	$775K	Sell	11,800 -600	-5%	-$37.1K	0.81%	61
2015 Q3	$701K	Sell	12,400 -600	-5%	-$38.9K	0.71%	70
2015 Q2	$769K	Sell	13,000 -1,000	-7%	-$61.7K	0.7%	71
2015 Q1	$873K	Buy	+14,000	New	+$814K	0.71%	62

Other funds holding TEVA

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Barrow, Hanley, Mewhinney & Strauss Dallas, Texas $30.5B AUM 29.95% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return

Lazard Asset Management New York $60.8B AUM 22.47% 1-Year Est. Return

WRF

Waddell & Reed Financial Overland Park, Kansas $48.6B AUM 84.78% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Paulson & Co New York $3.11B AUM 94.93% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Legg Mason Asset Management's TEVA Position: Q3 2016 in Review

Legg Mason Asset Management sold out of Teva Pharmaceuticals (TEVA) in Q3 2016, closing a stake of 11,500 shares — an estimated $578K sold.

Legg Mason Asset Management first reported a position in TEVA in Q1 2015 and held it in 6 quarters. The position peaked at $873K in Q1 2015. 795 funds tracked by Wall St. Rank hold TEVA as of Q3 2016.

Legg Mason Asset Management reported no remaining Teva Pharmaceuticals position as of Q3 2016 after selling out during the quarter.
Legg Mason Asset Management sold 11,500 Teva Pharmaceuticals shares in Q3 2016, an estimated $578K.
Legg Mason Asset Management first reported a position in Teva Pharmaceuticals in Q1 2015 and held it in 6 quarters.
Legg Mason Asset Management's Teva Pharmaceuticals position peaked at $873K in Q1 2015.
795 funds tracked by Wall St. Rank held Teva Pharmaceuticals as of Q3 2016.

Based on Legg Mason Asset Management's 13F filing for Q3 2016, filed 14 Nov 2016.